Capricor Therapeutics Financial Statements 2009-2025 | CAPR

Revenue

$22.271

$25.178

$2.552

$0.245

$0.31

$1.005

$1.671

$2.666

$3.999

$5.518

Cost Of Goods Sold

Gross Profit

$22.271

$25.178

$2.552

$0.245

$0.31

$1.005

$1.671

$2.666

$3.999

$5.518

Research And Development Expenses

$49.969

$36.448

$21.817

$13.571

$8.457

$5.142

$12.067

$10.766

$16.042

$13.757

SG&A Expenses

$14.867

$12.808

$10.432

$7.612

$5.543

$3.597

$4.932

$4.763

$4.933

$4.372

Other Operating Income Or Expenses

Operating Expenses

Operating Income

$-42.565

$-24.078

$-29.697

$-20.938

$-13.69

$-7.734

$-15.327

$-12.862

$-16.977

$-12.612

Total Non-Operating Income/Expense

$2.098

$1.79

$0.678

$0.916

$0.033

$0.092

$0.136

$15.294

$-1.83

$-0.246

Pre-Tax Income

$-40.467

$-22.288

$-29.02

$-20.023

$-13.657

$-7.642

$-15.191

$2.431

$-18.807

$-12.857

Income Taxes

Income After Taxes

$-40.467

$-22.288

$-29.02

$-20.023

$-13.657

$-7.642

$-15.191

$2.431

$-18.807

$-12.857

Other Income

Income From Continuous Operations

$-40.467

$-22.288

$-29.02

$-20.023

$-13.657

$-7.642

$-15.191

$2.431

$-18.807

$-12.857

Income From Discontinued Operations

Net Income

$-40.467

$-22.288

$-29.02

$-20.023

$-13.657

$-7.642

$-15.191

$2.431

$-18.807

$-12.857

EBITDA

$-41.14

$-23.009

$-29.164

$-20.693

$-13.546

$-7.562

$-15.169

$-12.718

$-16.851

$-12.501

EBIT

$-42.565

$-24.078

$-29.697

$-20.938

$-13.69

$-7.734

$-15.327

$-12.862

$-16.977

$-12.612

Basic Shares Outstanding

Shares Outstanding

Basic EPS

$-1.15

$-0.83

$-1.18

$-0.87

$-0.88

$-2.06

$-5.17

$1.00

$-10.10

$-8.10

EPS - Earnings Per Share

$-1.15

$-0.83

$-1.18

$-0.87

$-0.88

$-2.06

$-5.17

$0.90

$-10.10

$-8.10